Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tekla World Healthcare FundTHW +0.15%53 Debt-to-Equity is 0.25 as of Mar. 2026, which is 4% below its 10-year median of 0.26. GuruFocus rates THW with a GF Score™ of 53/100 and a GF Value™ of $19.36 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 962 Asset Management companies, Tekla World Healthcare Fund ranks worse than 54.05% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Tekla World Healthcare Fund's Debt-to-Equity or its related term are showing as below:
THW'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.21 Med: 0.26 Max: 0.32
Current: 0.25
During the past 9 years, the highest Debt-to-Equity Ratio of Tekla World Healthcare Fund was 0.32. The lowest was 0.21. And the median was 0.26.
THW's Debt-to-Equity is ranked worse than 54.05% of 962
companies
in the Asset Management industry
Industry Median: 0.21
vs THW: 0.25
Tekla World Healthcare Fund (NYSE:THW) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Tekla World Healthcare Fund Debt-to-Equity Related Terms
Tekla World Healthcare Fund Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, Tekla World Healthcare Fund's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tekla World Healthcare Fund Debt-to-Equity vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Tekla World Healthcare Fund's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Tekla World Healthcare Fund's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tekla World Healthcare Fund (THW) has a Debt-to-Equity of 0.25 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Tekla World Healthcare Fund and its competitors. This is near median its historical median of 0.26. Over the past decade, Tekla World Healthcare Fund's Debt-to-Equity has ranged from 0.21 to 0.32. According to the industry distribution chart, Tekla World Healthcare Fund ranks #520 out of 962 companies in the Asset Management industry, placing it in the top 54.1%.
Is Tekla World Healthcare Fund's Debt-to-Equity too high?
Tekla World Healthcare Fund's current Debt-to-Equity of 0.25 is near median its 10-year median of 0.26. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 0.32. The Asset Management industry median Debt-to-Equity is 0.21. Tekla World Healthcare Fund's value of 0.25 is 19% above this industry median. Based on the distribution chart, Tekla World Healthcare Fund ranks #520 out of 962 companies in the Asset Management industry, which is below the industry midpoint. Overall, Tekla World Healthcare Fund has a GF Score™ of 53/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tekla World Healthcare Fund's Debt-to-Equity compare to MSIF and IQI?
According to the Asset Management industry distribution chart, Tekla World Healthcare Fund ranks #520 out of 962 companies for Debt-to-Equity. This places Tekla World Healthcare Fund in the lower half of its industry. The industry median Debt-to-Equity is 0.21. Tekla World Healthcare Fund's value of 0.25 is 19% above this benchmark. Historically, Tekla World Healthcare Fund's own Debt-to-Equity has ranged from 0.21 to 0.32 over the past decade. While the company's 10-year median is 0.26 vs. the industry median of 0.21, Tekla World Healthcare Fund has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for an Asset Management company?
The median Debt-to-Equity among Asset Management companies is 0.21, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tekla World Healthcare Fund's current Debt-to-Equity of 0.25 is 19% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Tekla World Healthcare Fund and its competitors. For the Asset Management industry, the median Debt-to-Equity is 0.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tekla World Healthcare Fund's current Debt-to-Equity is 0.25, which is near median its own 10-year median of 0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tekla World Healthcare Fund stock overvalued right now?
Based on GuruFocus' analysis, Tekla World Healthcare Fund (THW) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.36, compared to a current price of $13.12 — trading 32.2% below its estimated fair value. The current Debt-to-Equity is 0.25, which is near median its 10-year median of 0.26 and 19% above the Asset Management industry median of 0.21. Tekla World Healthcare Fund's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Tekla World Healthcare Fund (THW), the current Debt-to-Equity is 0.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tekla World Healthcare Fund (THW) Overvalued in 2026?
Based on GuruFocus' analysis, Tekla World Healthcare Fund stock appears to be undervalued.
The current stock price of $13.12 is trading 32.2% below its estimated GF Value™ of $19.36.
GuruFocus considers Tekla World Healthcare Fund to be Significantly Undervalued.
Key valuation signals for THW:
Debt-to-Equity: 0.25 (near median its 10-year median of 0.26)
GF Value™: $19.36 vs. price of $13.12 (32.2% below fair value)
Industry Position: 19% above the Asset Management median (#520 of 962)
No single metric tells the full story. See the THW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.
53GF Score
Get the complete analysis for THW
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
THW has been successfully added to your 
